For further information please fill the details below:

First Name
Last Name
Mobile Number
Email Address
Program Enquired
School Enquired
Home >
Dr. Kavita H. Singh

Dr. Kavita H. Singh

Assistant Professor


M.Pharm., Ph.D. (Tech.) , PGDPL

Email Id

Phone No.

+91-022-42332000 (Extn- 2024)

Experience : 7 years (Industry: 2 years, Academics: 5 years)

She has 2 years’ work experience in industries like Pfizer India Pvt. Ltd. and Ipca Labs Pvt. Ltd. She has worked as Senior Research Fellow for research project sponsored by Relmada Therapeutics, USA during doctoral research.

Interest areas:

Expertise in development of various formulations viz. Polymeric and lipid based Nano carriers, Novel ophthalmic drug delivery systems, Osmotic drug delivery systems, Colon targeted and extended release matrix based oral solid dosage forms, antiaging interventions, Pharmacokinetic studies etc. She carries keen interest in exploring novel anti-aging modalities and is engaged in multiple projects in this arena.


  • Publications – 15 (International - 11, National - 04) 
  • Book Chapters – 01 
  • Patents – 02 (Filed)
  • Presentations - 22 (International- 6, National- 16)

Government funded projects - 02

  • Received Research grant of approx. 41 Lacs under the scheme, Early Career Research Award of Science & Engineering Research Board (SERB), DST, Govt. of India for the project entitled "Development and assessment of novel formulations containing therapeutic proteins and siRNA for treatment of Diabetic retinopathy.”
  • Polymeric Nanoparticulate systems have been developed for an antiglaucoma agent to prolong the release of drug to the Ocular Membrane funded by University of Mumbai. (Rs. 22,000).

Industry projects handled - 06

  • Development of novel Anti-aging modalities; funded by Nugenics Research Pvt Ltd, Mumbai, India. (Approx. Rs. 25 lacs).
  • Pharmacokinetic Evaluation of Curcumin Formulation with Gelucire 48/16; funded by Gattefosse India Pvt. Ltd., Mumbai, India. (Approx. Rs. 5 lacs).
  • Development of oral modified release formulations such as Push pull osmotic pumps, controlled porosity osmotic pumps, extended release matrix tablets, ileo-colonic nano-delivery systems for Cyp 3A4 substrate used in pain management; funded by Relmada Therapeutics , USA (Rs. 5 lacs).
  • "iDisso setup and visual monitoring studies” & "Statistical Assessment of Drug Release Profiles and Analysis of Dissolution Aliquots Subjected to Varied Dilution and Mixing Efficiency” for ELECTROLAB, Mumbai.
  • "Evaluation of Dermatological Products: Ex-vivo diffusion and permeation studies through human cadaver skin”, for CLAIMS Pvt Ltd, Mumbai.
  • "Herbal formulation development” for Vedic Life Sciences, Mumbai

Conferences/Workshops/Seminars attended

More than 25

Academic activities

She has guided 6 M.Pharm. students for their research projects.

She has 2 Junior research fellows working under her supervision on Government and Industry funded research projects.

  • Dr. Kavita Singh is appointed as Technical Expert for E-content and video development for Units of Physical Pharmacy under National mission on education through information and communication (NMEICT), Consortium for Educational Communication, UGC MHRD PROJECT by Educational Multimedia Research Centre (EMMRC) as per the guidelines framed by UGC, Consortium for Educational Communication.
  • Appointed as External referee for conducting Viva-Voce examinations of M. Pharm. (Pharmaceutics) students from University of Mumbai.


  • Received international travel support of Rs. 2 lacs to present research work entitled - Development and Evaluation of Hydrogel Based Contact Lens of Ganciclovir for Treatment of Cytomegalovirus Retinitis, at 2017 AAPS Annual Meeting and Exposition, held in San Diego, USA from 12-11-2017 to 15-11-2017.
  • Received 3rd prize for oral presentation on project entitled "Formulation and development of gabapentin–loaded lipid nanoparticle gel” in a conference on Novel Formulation Strategies, held on 12-13 April 2018 at Ramada Powai Hotel and Convention Centre, Mumbai, India.
  • Received Research grant of Rs. 38 Lakhs under the scheme, Early Career Research Award of Science & Engineering Research Board (SERB), DST, Govt. of India for the project entitled "Development and assessment of novel formulations containing therapeutic proteins and siRNA for treatment of Diabetic retinopathy.” 
  • Obtained 4th rank in P.G. Diploma in Patent Law from NALSAR University of Law, Hyderabad, India in May 2017 with A+ grade.
  • First Prize for poster presentation entitled "Investigation of In-vitro In vivo release profiles of Buprenorphine HCl loaded nanoparticles for colon targeting” at DISSO INDIA 2013, International Annual Symposium organized by Society of Pharmaceutical Dissolution Science at Mumbai, India.
  • Awarded Senior Research Fellowship for the doctoral research by Council of Scientific and Industrial Research, Govt. of India, New Delhi, India in April 2012.
  • Ratan Tata scholarship, Sir Dorabji Tata Trust, Fort, Mumbai for the Year 2001-2002.

Professional Memberships

  • Life member of Indian Pharmaceutical Association 
  • Life member of Association of Pharmaceutical Teachers of India

Recent Publications

  • Ujwala Shinde, Sheela Modani and Kavita Singh. Design and Development of Repaglinide Microemulsion Gel for Transdermal Delivery. AAPS Pharm SciTech. Accepted in May 2017. 
  • Anjali Kudtarkar, Ujwala Shinde, Gopal Bharkad and Kavita Singh. Solid lipid nanoparticles of albendazole for treatment of toxocara canis infection: in-vivo efficacy studies. Nanoscience & Nanotechnology-Asia, 2016; 6(3):1-12. 
  • Shinde UA, Shete JN, Nair HA, Singh KH. Design and characterization of chitosan-alginate microspheres for ocular delivery of azelastine. Pharmaceutical Development and Technology. 2014 Nov; 19(7):813-823. 
  • Noorjahan A, Amrita B, Kavita S. In vivo evaluation of taste masking for developed chewable and orodispersible tablets in humans and rats. Pharmaceutical Development and Technology. 2014 May; 19(3):290-295. 
  • Shinde U, Ahmed MH, Singh K. Development of dorzolamide loaded 6-o-carboxymethyl chitosan nanoparticles for open angle glaucoma. Journal of Drug Delivery. 2013:562727. 
  • Singh, K.; Bajaj, A.; Babul, N.; Kao, H. Controlled 24 hour oral delivery of buprenorphine using a push pull osmotic pump. Journal of Pain. 2012, 13(4):S78.
© Copyright 2021. Shri Vile Parle Kelavani Mandal (SVKM) All Rights Reserved.   Disclaimer  |  Privacy Policy